| scholarly article | Q13442814 |
| P356 | DOI | 10.1023/A:1012013113759 |
| P698 | PubMed publication ID | 9090714 |
| P2093 | author name string | A H Kung | |
| R J Bauer | |||
| J Barrientos | |||
| K Der | |||
| N Ottah-Ihejeto | |||
| P2860 | cites work | Cloning of the cDNA of a human neutrophil bactericidal protein. Structural and functional correlations | Q24339484 |
| Human bactericidal/permeability-increasing protein and a recombinant NH2-terminal fragment cause killing of serum-resistant gram-negative bacteria in whole blood and inhibit tumor necrosis factor release induced by the bacteria | Q35822718 | ||
| Heparin affinity of anionic and cationic capillary endothelial cell growth factors: analysis of hypothalamus-derived growth factors and fibroblast growth factors | Q37676846 | ||
| Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy | Q37943123 | ||
| Clearance approaches in pharmacology. | Q39765862 | ||
| High-affinity binding of the bactericidal/permeability-increasing protein and a recombinant amino-terminal fragment to the lipid A region of lipopolysaccharide | Q40152200 | ||
| Bactericidal/permeability-increasing protein ameliorates acute lung injury in porcine endotoxemia | Q43474863 | ||
| Recombinant amino terminal fragment of bactericidal/permeability-increasing protein prevents hemodynamic responses to endotoxin | Q46045448 | ||
| Nonlinear pharmacokinetics of recombinant human macrophage colony-stimulating factor (M-CSF) in rats. | Q46060973 | ||
| Expression and characterization of cysteine-modified variants of an amino-terminal fragment of bactericidal/permeability-increasing protein | Q46189668 | ||
| Functional domains of recombinant bactericidal/permeability increasing protein (rBPI23). | Q46200360 | ||
| Drug Absorption and Metabolism Studies by Use of Portal Vein Infusion in the Rat. I. Pyloric Vein Cannulation and Its Application to Study of First-Pass Effect on Bioavailability of Propranolol | Q53925665 | ||
| Normal hemodynamic parameters in conscious Wistar rats. | Q54439670 | ||
| Inhibition of endotoxin-induced cytokine release and neutrophil activation in humans by use of recombinant bactericidal/permeability-increasing protein. | Q54609188 | ||
| Prognostic Values of Tumor Necrosis Factor/Cachectin, Interleukin-l, Interferon- , and Interferon- in the Serum of Patients with Septic Shock | Q64132947 | ||
| Liver heparan sulfate structure. A novel molecular design | Q64146700 | ||
| Nonlinear pharmacokinetics of tissue-type plasminogen activator in three animal species and isolated perfused rat liver | Q68359525 | ||
| Heparin protects basic and acidic FGF from inactivation | Q68895706 | ||
| The fate of intravenously administered bFGF and the effect of heparin | Q69447125 | ||
| Clearance of human platelet factor 4 by liver and kidney: its alteration by heparin | Q69633980 | ||
| Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance | Q69817892 | ||
| Binding of platelet factor 4 to cultured human umbilical vein endothelial cells | Q71417814 | ||
| Measurement of bactericidal/permeability-increasing protein in human body fluids by sandwich ELISA | Q71609815 | ||
| Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation | Q72624425 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 224-229 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Pharmaceutical Research | Q7180737 |
| P1476 | title | The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats | |
| P478 | volume | 14 |
Search more.